While the tax exclusion for employer-sponsored health care was not included in the House-passed reconciliation bill, it ...

A new analysis of obesity guidelines suggests more evidence is needed to develop stronger guidelines for the transition ...

Cemiplimab improved disease-free survival in patients with high-risk cutaneous squamous cell carcinoma (CSCC) and performed ...

Real-world data show no significant differences in overall survival between patients with or without cytogenetic risk factors ...

Outcomes were evaluated among children born between April 1980 and June 2019 by using data from 12 observational birth ...

A combination of acalabrutinib and venetoclax showed better results with the addition of obinutuzumab, whereas mixed findings ...

Nonalcoholic fatty liver disease (NAFLD) was linked to elevated liver enzymes in type 2 diabetes mellitus (T2DM) in a recent ...

The findings support the clinical benefits of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) ...

The Trump administration has ended a program seeking a vaccine for HIV, the first in a series of decisions that is leaving ...

Bringing this interview with Marla Black Morgan, MD, to a close, she looks to the future of research in both myasthenia ...

Skepticism still persists around the use of measurable residual disease (MRD) for clinical and regulatory decision-making in ...

Early results from the phase 1 SANRECO trial suggest that divesiran is safe and well tolerated, and may reduce the need for phlebotomy in patients with polycythemia vera by increasing hepcidin levels ...